CL2004001019A1 - Sal de adicion de acido 1,5-naftaleno disulfonico de [(7r,8r,9r)-2,3-dimetil-8-hidroxi-7-(2-metoxi-etoxi)9-fenil-7,8,9,10-tetrahidro-imidazo-[1,2-h][1,7]naftiridina]; procedimiento de preparacion de dicha sal de adicion; y uso de la sal como compuest - Google Patents
Sal de adicion de acido 1,5-naftaleno disulfonico de [(7r,8r,9r)-2,3-dimetil-8-hidroxi-7-(2-metoxi-etoxi)9-fenil-7,8,9,10-tetrahidro-imidazo-[1,2-h][1,7]naftiridina]; procedimiento de preparacion de dicha sal de adicion; y uso de la sal como compuestInfo
- Publication number
- CL2004001019A1 CL2004001019A1 CL200401019A CL2004001019A CL2004001019A1 CL 2004001019 A1 CL2004001019 A1 CL 2004001019A1 CL 200401019 A CL200401019 A CL 200401019A CL 2004001019 A CL2004001019 A CL 2004001019A CL 2004001019 A1 CL2004001019 A1 CL 2004001019A1
- Authority
- CL
- Chile
- Prior art keywords
- addition salt
- salt
- preparation
- disulfonico
- compuest
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
EL INVENTO SE REFIERE A LA SAL POR ADICION DE ACIDO 1,5-NAFTALENO DISULFONICO DEL COMPUESTO DE LA FORMULA I. EL COMPUESTO DE ACUERDO CON EL INVENTO ES UN VALIOSO COMPUESTO INTERMEDIARIO PARA LA PREPARACION DE COMPUESTOS TERAPEUTICAMENTE ACTIVOS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03010785 | 2003-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2004001019A1 true CL2004001019A1 (es) | 2005-03-04 |
Family
ID=33442723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL200401019A CL2004001019A1 (es) | 2003-05-14 | 2004-05-12 | Sal de adicion de acido 1,5-naftaleno disulfonico de [(7r,8r,9r)-2,3-dimetil-8-hidroxi-7-(2-metoxi-etoxi)9-fenil-7,8,9,10-tetrahidro-imidazo-[1,2-h][1,7]naftiridina]; procedimiento de preparacion de dicha sal de adicion; y uso de la sal como compuest |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US20060235228A1 (es) |
| EP (1) | EP1631571B1 (es) |
| JP (1) | JP2007502852A (es) |
| KR (1) | KR20060012593A (es) |
| CN (1) | CN100361991C (es) |
| AR (1) | AR044288A1 (es) |
| AT (1) | ATE393155T1 (es) |
| AU (1) | AU2004238570A1 (es) |
| BR (1) | BRPI0410084A (es) |
| CA (1) | CA2525038A1 (es) |
| CL (1) | CL2004001019A1 (es) |
| DE (1) | DE602004013311D1 (es) |
| EA (1) | EA008746B1 (es) |
| EC (1) | ECSP056055A (es) |
| GE (1) | GEP20084394B (es) |
| IS (1) | IS8163A (es) |
| MX (1) | MXPA05011859A (es) |
| MY (1) | MY141657A (es) |
| NO (1) | NO20055755L (es) |
| NZ (1) | NZ543913A (es) |
| PE (1) | PE20050155A1 (es) |
| RS (1) | RS20050824A (es) |
| SA (1) | SA04250092B1 (es) |
| TW (1) | TW200503701A (es) |
| UA (1) | UA81036C2 (es) |
| WO (1) | WO2004101566A1 (es) |
| ZA (1) | ZA200507741B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112018001859B1 (pt) | 2015-07-30 | 2023-05-02 | Takeda Pharmaceutical Company Limited | Comprimido, e, método para produzir um comprimido |
| US20230060797A1 (en) * | 2021-09-02 | 2023-03-02 | Jcr Pharmaceuticals Co., Ltd. | Therapeutic compound for neuronal ceroid lipofuscinosis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2011078C3 (de) * | 1970-03-09 | 1974-11-14 | Goedecke Ag, 1000 Berlin | Verfahren zur Reinigung von Hexetidin |
| PL193616B1 (pl) * | 1998-09-23 | 2007-02-28 | Altana Pharma Ag | Tetrahydropirydoetery |
| BR0109483A (pt) * | 2000-03-29 | 2003-06-10 | Altana Pharma Ag | Pró-drogas de derivados de imidazopiridina |
-
2004
- 2004-04-26 SA SA4250092A patent/SA04250092B1/ar unknown
- 2004-05-03 RS YUP-2005/0824A patent/RS20050824A/sr unknown
- 2004-05-11 MY MYPI20041747A patent/MY141657A/en unknown
- 2004-05-11 PE PE2004000485A patent/PE20050155A1/es not_active Application Discontinuation
- 2004-05-11 AR ARP040101591A patent/AR044288A1/es not_active Application Discontinuation
- 2004-05-12 CL CL200401019A patent/CL2004001019A1/es unknown
- 2004-05-13 KR KR1020057021015A patent/KR20060012593A/ko not_active Application Discontinuation
- 2004-05-13 MX MXPA05011859A patent/MXPA05011859A/es not_active Application Discontinuation
- 2004-05-13 US US10/555,793 patent/US20060235228A1/en not_active Abandoned
- 2004-05-13 NZ NZ543913A patent/NZ543913A/en unknown
- 2004-05-13 CN CNB200480011797XA patent/CN100361991C/zh not_active Expired - Fee Related
- 2004-05-13 CA CA002525038A patent/CA2525038A1/en not_active Abandoned
- 2004-05-13 WO PCT/EP2004/050780 patent/WO2004101566A1/en active IP Right Grant
- 2004-05-13 BR BRPI0410084-0A patent/BRPI0410084A/pt not_active IP Right Cessation
- 2004-05-13 GE GEAP20049113A patent/GEP20084394B/en unknown
- 2004-05-13 EA EA200501691A patent/EA008746B1/ru not_active IP Right Cessation
- 2004-05-13 AU AU2004238570A patent/AU2004238570A1/en not_active Abandoned
- 2004-05-13 AT AT04741560T patent/ATE393155T1/de not_active IP Right Cessation
- 2004-05-13 UA UAA200511529A patent/UA81036C2/uk unknown
- 2004-05-13 DE DE602004013311T patent/DE602004013311D1/de not_active Expired - Fee Related
- 2004-05-13 JP JP2006530186A patent/JP2007502852A/ja not_active Withdrawn
- 2004-05-13 EP EP04741560A patent/EP1631571B1/en not_active Expired - Lifetime
- 2004-05-14 TW TW093113749A patent/TW200503701A/zh unknown
-
2005
- 2005-09-26 ZA ZA200507741A patent/ZA200507741B/xx unknown
- 2005-09-28 EC EC2005006055A patent/ECSP056055A/es unknown
- 2005-12-01 IS IS8163A patent/IS8163A/is unknown
- 2005-12-05 NO NO20055755A patent/NO20055755L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE20050155A1 (es) | 2005-03-22 |
| NZ543913A (en) | 2008-02-29 |
| ECSP056055A (es) | 2006-01-27 |
| TW200503701A (en) | 2005-02-01 |
| NO20055755L (no) | 2005-12-05 |
| CA2525038A1 (en) | 2004-11-25 |
| EA200501691A1 (ru) | 2006-06-30 |
| AU2004238570A1 (en) | 2004-11-25 |
| SA04250092B1 (ar) | 2008-05-04 |
| KR20060012593A (ko) | 2006-02-08 |
| UA81036C2 (en) | 2007-11-26 |
| EP1631571A1 (en) | 2006-03-08 |
| MY141657A (en) | 2010-05-31 |
| RS20050824A (en) | 2007-12-31 |
| JP2007502852A (ja) | 2007-02-15 |
| EA008746B1 (ru) | 2007-08-31 |
| CN1780839A (zh) | 2006-05-31 |
| IS8163A (is) | 2005-12-01 |
| US20060235228A1 (en) | 2006-10-19 |
| WO2004101566A8 (en) | 2007-04-26 |
| EP1631571B1 (en) | 2008-04-23 |
| ATE393155T1 (de) | 2008-05-15 |
| ZA200507741B (en) | 2008-08-27 |
| AR044288A1 (es) | 2005-09-07 |
| WO2004101566A1 (en) | 2004-11-25 |
| DE602004013311D1 (de) | 2008-06-05 |
| GEP20084394B (en) | 2008-06-10 |
| BRPI0410084A (pt) | 2006-05-16 |
| MXPA05011859A (es) | 2006-02-17 |
| CN100361991C (zh) | 2008-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE540932T1 (de) | Hydantoin-derivate als antibakterielle wirkstoffe | |
| MX340214B (es) | Procedimiento para la preparación de compuestos útiles como inhibidores del transportador de glucosa dependiente de sodio 2. | |
| CY1113873T1 (el) | Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90 | |
| AR029857A1 (es) | Derivados de acidos sulfonil-amino-metil-benzoicos sustituidos y procedimiento para su preparacion | |
| EA201101672A1 (ru) | Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина | |
| DOP2006000170A (es) | Nuevos derivados de espirocromanona | |
| AR047739A1 (es) | Polimorfos cristalinos de un ligando receptor de cxc-quimiocina | |
| BRPI0408353A (pt) | composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto | |
| ECSP088368A (es) | Derivados de 3-alquil-5-(4-alquil-5-oxo-tetrahidrofuran-2-il)-pirrolidin-2-ona como intermediarios en la síntesis de inhibidores de renina | |
| EA200600621A1 (ru) | Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
| BR112023015976A2 (pt) | Compostos de anel aromático de pirimidina | |
| PE20050012A1 (es) | Compuestos de benzopirano como inhibidores de la ciclooxigenasa-2 | |
| AR057909A1 (es) | Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico. | |
| EA022994B1 (ru) | Способ подавления толерантности к опиоидному анальгетику | |
| TW200710084A (en) | Process for the synthesis of organic compounds | |
| EA200700550A1 (ru) | Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
| UY26951A1 (es) | Derivados de ácido propiónico | |
| UY32744A (es) | Derivados de 2-carboxamida-7-piperazinil-benzofurano 774 | |
| AR041937A1 (es) | Proceso para la preparacion de derivados de carboestirilo | |
| CL2004001019A1 (es) | Sal de adicion de acido 1,5-naftaleno disulfonico de [(7r,8r,9r)-2,3-dimetil-8-hidroxi-7-(2-metoxi-etoxi)9-fenil-7,8,9,10-tetrahidro-imidazo-[1,2-h][1,7]naftiridina]; procedimiento de preparacion de dicha sal de adicion; y uso de la sal como compuest | |
| BR112014000613A2 (pt) | método para a preparação de ácido ciclo-hexanocarboxílico | |
| PT1406865E (pt) | Derivados de acido succinico | |
| DOP2001000260A (es) | Derivados de acido propinoico | |
| EA200801615A1 (ru) | Оптические изомеры дигидро-2,3-бензодиазепинов и их стереоселективный синтез | |
| BRPI0807799A2 (pt) | " derivados de 2-piperazin-1-il-3h-imidazo{4,5-b]piridina". |